Print

ACADIA Pharmaceuticals, Inc. (ACAD) to Present at the Oppenheimer 23rd Annual Healthcare Conference Today, December 12, 2012  
12/12/2012 9:26:28 AM

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, announced that it will present at the Oppenheimer 23rd Annual Healthcare Conference later today, Wednesday, December 12, 2012, at 3:55 p.m. Eastern Time at The Waldorf=Astoria Hotel in New York City.
//-->